201 related articles for article (PubMed ID: 28315369)
21. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
22. Fulvestrant, a selective estrogen receptor down-regulator, sensitizes estrogen receptor negative breast tumors to chemotherapy.
Jiang D; Huang Y; Han N; Xu M; Xu L; Zhou L; Wang S; Fan W
Cancer Lett; 2014 May; 346(2):292-9. PubMed ID: 24462822
[TBL] [Abstract][Full Text] [Related]
23. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells.
Serrero G; Lu R
Antioxid Redox Signal; 2001 Dec; 3(6):969-79. PubMed ID: 11813992
[TBL] [Abstract][Full Text] [Related]
24. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment.
Chimento A; Sirianni R; Saturnino C; Caruso A; Sinicropi MS; Pezzi V
Mini Rev Med Chem; 2016; 16(9):699-709. PubMed ID: 26996623
[TBL] [Abstract][Full Text] [Related]
26. [Review on experimental research of Chinese herbal medicine intervenion for breast cancer].
Zhou QM; Su SB
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1947-50. PubMed ID: 18051911
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells.
Medina-Aguilar R; Marchat LA; Arechaga Ocampo E; Gariglio P; García Mena J; Villegas Sepúlveda N; Martínez Castillo M; López-Camarillo C
Oncol Rep; 2016 Jun; 35(6):3696-704. PubMed ID: 27109433
[TBL] [Abstract][Full Text] [Related]
28. Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene.
Ito Y; Mitani T; Harada N; Isayama A; Tanimori S; Takenaka S; Nakano Y; Inui H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):358-64. PubMed ID: 24064738
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
30. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol dimer trans-ε-viniferin prevents rotaviral diarrhea in mice by inhibition of the intestinal calcium-activated chloride channel.
Yu B; Jiang Y; Zhang B; Yang H; Ma T
Pharmacol Res; 2018 Mar; 129():453-461. PubMed ID: 29155014
[TBL] [Abstract][Full Text] [Related]
32. Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells.
Chen FP; Chien MH
Climacteric; 2014 Aug; 17(4):385-92. PubMed ID: 24299158
[TBL] [Abstract][Full Text] [Related]
33. Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.
Wesolowska O; Wisniewski J; Bielawska-Pohl A; Paprocka M; Duarte N; Ferreira MJ; Dus D; Michalak K
Anticancer Res; 2010 Nov; 30(11):4587-93. PubMed ID: 21115910
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines.
Sala M; Chimento A; Saturnino C; Gomez-Monterrey IM; Musella S; Bertamino A; Milite C; Sinicropi MS; Caruso A; Sirianni R; Tortorella P; Novellino E; Campiglia P; Pezzi V
Bioorg Med Chem Lett; 2013 Sep; 23(17):4990-5. PubMed ID: 23860590
[TBL] [Abstract][Full Text] [Related]
35. Palmitic acid increases pro-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: Action of resveratrol.
Favre J; Yildirim C; Leyen TA; Chen WJ; van Genugten RE; van Golen LW; Garcia-Vallejo JJ; Musters R; Baggen J; Fontijn R; van der Pouw Kraan T; Serné E; Koolwijk P; Diamant M; Horrevoets AJ
Vascul Pharmacol; 2015 Dec; 75():7-18. PubMed ID: 26254104
[TBL] [Abstract][Full Text] [Related]
36. Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines.
Le Corre L; Fustier P; Chalabi N; Bignon YJ; Bernard-Gallon D
Clin Chim Acta; 2004 Jun; 344(1-2):115-21. PubMed ID: 15149879
[TBL] [Abstract][Full Text] [Related]
37. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
[TBL] [Abstract][Full Text] [Related]
38. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
39. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro.
Limer JL; Parkes AT; Speirs V
Int J Cancer; 2006 Aug; 119(3):515-21. PubMed ID: 16506217
[TBL] [Abstract][Full Text] [Related]
40. Developing phytoestrogens for breast cancer prevention.
Liu MM; Huang Y; Wang J
Anticancer Agents Med Chem; 2012 Dec; 12(10):1306-13. PubMed ID: 22583409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
